MAM-2201

MAM-2201 is a drug that is a synthetic cannabinoid featuring an alkyl side chain. It is a full agonist for the CB1 receptor and CB2 receptor. MAM-2201 is part of a series of JWH-018 amide derivatives and was originally developed by the pharmaceutical company Organon International.

Chemistry

MAM-2201 is a synthetic cannabinoid that is derived from JWH-018. It is an amide derivative of JWH-018, which means it has an amide group (-CONH2) attached to the pentyl chain of JWH-018. The chemical formula of MAM-2201 is C25H24FNO.

Pharmacology

MAM-2201 is a full agonist for the CB1 and CB2 receptors. The CB1 receptor is primarily located in the brain and affects mood, appetite, and pain sensation. The CB2 receptor is primarily found in the immune system and affects inflammation and pain.

Effects

The effects of MAM-2201 are similar to those of other synthetic cannabinoids and include euphoria, relaxation, and altered perception. However, MAM-2201 is more potent than JWH-018, and its effects can be unpredictable and potentially harmful.

Legal Status

MAM-2201 is illegal in many countries, including the United States, where it is classified as a Schedule I drug. It is also illegal in the United Kingdom, where it is classified as a Class B drug.

See Also

• JWH-018
• Synthetic cannabinoids
• CB1 receptor
• CB2 receptor

MAM-2201 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski